From the publisher feed
The treatment, called ivonescimab, has become a symbol of China’s rise in drug development.
Read the original at The New York Times ↗Opens the original publisher page. Access, copyright and subscriptions are controlled by the publisher.
A useful next step
- Read the short publisher description here.
- Open the full report directly at the publisher.
- Compare this topic with other sources when useful.